The oligonucleotide synthesis services market is projected to reach $4.7 billion by 2030 at a 10.0% CAGR, driven by gene therapy, CRISPR demand, and GMP oligo production.
Read More
The offloading devices market is projected to reach $10.2 billion by 2030 at a 6.9% CAGR, driven by diabetes care, preventive wound management, and custom orthotics.
Read More
The neuroendocrine prostate cancer market is projected to reach $1.6 billion by 2030 at an 8.7% CAGR, driven by precision oncology, biomarkers, and targeted therapies.
Read More
The neural control market is projected to reach $4.72 billion by 2030 at a 13.8% CAGR, driven by BCI solutions, neural rehabilitation, and assistive neuro-robotics.
Read More
The nervous system API market is projected to reach $334.12 billion by 2030 at a 5.6% CAGR, driven by CNS therapies, neurodegenerative treatments, and high-purity API demand.
Read More
The multiport surgical robot market is set to reach $6.93 billion by 2030 at a 19.1% CAGR, driven by complex robotic procedures, AI-assisted surgery, and minimally invasive robotics.
Read More
The multimodal imaging market is projected to reach $6 billion by 2030 at a 6.8% CAGR, driven by hybrid imaging systems, AI analytics, and precision diagnostics demand.
Read More
The monogenetic disease therapy market is set to reach $45.58 billion by 2030 at a 10.0% CAGR, driven by gene editing advances and precision genetic treatments.
Read More
The mobile health monitoring diagnostic device market is projected to reach $107.69 billion by 2030 at a 19.8% CAGR, driven by remote diagnostics and connected care growth.
Read More
The mobile health (mHealth) device market is set to reach $105.17 billion by 2030 at a 14.7% CAGR, driven by wearables, remote monitoring, and connected care solutions.
Read More